Latest News and Press Releases
Want to stay updated on the latest news?
-
Tampa, Florida, April 17, 2026 (GLOBE NEWSWIRE) -- Global Widget, LLC, a leading U.S.-based contract manufacturer specializing in gummy supplements, is celebrating its 10-year anniversary after a...
-
Houston, Texas, April 17, 2026 (GLOBE NEWSWIRE) -- Wilcrest Pharmaceuticals, Inc. (Wilcrest Pharma) has been awarded a national group purchasing agreement for Outsourced Compounded Preparations with...
-
– Updated presentation on Cogent’s potent pan-KRAS(ON) inhibitor, CGT1263, showcasing its selectivity profile which could lead to reduction in skin toxicity associated with multi-RAS inhibitors –...
-
PHILADELPHIA, April 17, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical development...
-
Newly published peer reviewed publications reinforce shift toward ammonia-directed treatment strategies in HE as rifaximin use comes under scrutiny
-
Live event to be held on Thursday, April 23, at 2:00 p.m. ET Company focused on advancing launch strategy ahead of November 14 PDUFA target action date NEW HAVEN, Conn., April 17, 2026 (GLOBE...
-
San Francisco, California, USA, April 17, 2026 (GLOBE NEWSWIRE) -- US Capital Global Securities LLC, the SEC-registered broker-dealer affiliate of the global financial group US Capital Global, is...
-
Data from subset analysis of cabozantinib-pretreated patients support potential to overcome resistance and resensitize tumors to VEGF TKI therapy 44% ORR and 94% DCR in ccRCC patients previously...
-
TUCSON, Ariz., April 16, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard Medical” or the “Company”), parent company of SynCardia Systems, LLC, (“SynCardia”) maker of the...
-
Presentations highlight therapy-induced senescence as a new opportunity and reinforce STX-1’s potential as a differentiated approach in solid tumors.